By Hagop Kantarjian, Donald W. Light and Vivian Ho
The authors assess the Trump administration's plan to bring down drug prices and its potential implications for the cost of cancer drugs. American Journal of Hematology (subscription required): http://bit.ly/2QM0yZf.
